Sport psychiatry: A systematic review of diagnosis and medical treatment of mental Illness in athletes

Sports Medicine

Volumn 40, Issue 11, 2010, Pages 961-980

  Reardon, Claudia L ^a   Factor, Robert M ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Antidepressants, therapeutic use; Antipsychotics, therapeutic use; Anxiolytics, therapeutic use; Attention deficit hyperactivity disorder; Hypnosedatives, therapeutic use; Impulse control disorders; Obsessive compulsive disorders; Psychiatric disorders, Diagnosis; Psychiatric disorders, Treatment; Sports

Indexed keywords

ATHLETE; FEMALE; HUMAN; MALE; MENTAL DISEASE; PSYCHIATRY; PSYCHOLOGICAL ASPECT; REVIEW;

ATHLETES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PSYCHIATRY;

EID: 77957962449     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.2165/11536580-000000000-00000     Document Type: Review

References (103)

1. Begel D. Family systems-based treatment of the athlete family. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 206-28
2. Glick ID, Kamm R, Morse E. The evolution of sport psychiatry, circa 2009. Sports Med 2009; 39 (8): 607-13
3. Hellstedt J. Invisible players: a family systems model. Clin Sports Med 2005; 24 (4): 899-928
4. McDuff DR, Morse ED, White RK. Professional and collegiate team assistance programs: services and utilization patterns. Clin Sports Med 2005; 24 (4): 943-58
5. Kamm RL. The sport psychiatry examination. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 159-90
6. Glick ID, Horsfall JL. Diagnosis and psychiatric treatment of athletes. Clin Sports Med 2005; 24 (4): 771-81
7. Baum AL. Sport psychiatry: how to keep athletes in the game of life, on or off the field. Curr Psychiatry 2003; 2 (1): 51-6
8. Baum AL. Psychopharmacology in athletes. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 249-59
9. Burton RW. Mental illness in athletes. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 61-81
10. Oler MJ, Mainous AG, Martin CA, et al. Depression, suicidal ideation, and substance use among adolescents: are athletes at less risk? Arch Fam Med 1994; 3: 781-3
11. Yang J, Peek-Asa C, Corlette JD, et al. Prevalence of and risk factors associated with symptoms of depression in competitive collegiate student athletes. Clin J Sport Med 2007; 17 (6): 481-7
12. Puffer JC, McShane JM. Depression and chronic fatigue in the college student-athlete. Prim Care 1991; 18 (2): 297-308
13. Donohue B, Covassin T, Lancer K. Examination of psychiatric symptoms in student athletes. J Gen Psychol 2004; 131: 29-36
14. Rosen LW, Smokler C, Carrier D, et al. Seasonal mood disturbances in collegiate hockey players. J Athl Train 1996; 31 (3): 225-8
15. Kasper S, Rogers SLB, Yancey A, et al. Phototherapy in individuals with and without subsyndromal seasonal affective disorder. Arch Gen Psychiatry 1989; 46: 837-44
16. Macleod AD. Sport psychiatry. Aust N Z J Psychiatry 1998; 32: 860-6
17. Armstrong LE, VanHeest JL. The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology. Sports Med 2002; 32: 185-209
18. Morgan WP, Brown DR, Raglin JS, et al. Psychological monitoring of overtraining and staleness. Br J Sports Med 1987; 21 (3): 107-14
19. Schwenk TL. The stigmatization and denial of mental illness in athletes. Br J Sports Med 2000; 34 (1): 4-5
20. McCann S. Overtraining and burnout. In: Murphy SM, editor. Sport psychology interventions. Champaign (IL): Human Kinetics, 1995: 347-65
21. Callister R, Callister RK, Fleck SJ, et al. Physiological and performance responses to overtraining in elite judo athletes. Med Sci Sports Exerc 1989; 22: 816-24
22. Costill DL, Flynn MG, Kirwin JP, et al. Effects of repeated days of intensified training on muscle glycogen and swimming performance. Med Sci Sports Exerc 1998; 20: 249-54
23. Hackney AC, Pearman SN, Nowacki JM. Physiological profiles of overtrained and stale athletes: a review. Appl Sport Psychol 1990; 2: 21-33
24. Parham WD. The intercollegiate athlete: a 1990s profile. Couns Psychol 1993; 21: 411-29
25. Backmand H, Kaprio J, Kujala U, et al. Influence of physical activity on depression and anxiety of former elite athletes. Int J Sports Med 2003; 24: 609-16
26. Schwenk TL, Gorenflo DW, Dopp RR, et al. Depression and pain in retired professional football players. Med Sci Sports Exerc 2007; 39 (4): 599-605
27. Baum AL. Suicide in athletes: a review and commentary. Clin Sports Med 2005; 24 (4): 853-69
28. Smith AM, Milliner EK. Injured athletes and the risk of suicide. J Athl Train 1987; 29: 337-41
29. Smith AM, Scott SG, Wiese DM. The psychological effects of sports injuries: coping. Sports Med 1990; 9: 353-69
30. Begel D. The psychopathology of everyday athletic life. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 82-92
31. Kamm RL. Interviewing principles for the psychiatrically aware sports medicine physician. Clin Sports Med 2005; 24 (4): 745-69
32. Northon PJ, Burns JA, Hope DA. Generalization of social anxiety to sporting and athletic situations: gender, sports involvement, and parental pressure. Depress Anxiety 2000; 12: 193-202
33. Glasser W. Positive addiction. New York (NY): Harper and Row, 1976
34. Sachs ML, Pargman D. Running addiction: a depth interview examination. J Sport Behav 1979; 2: 143-55
35. Yates A, Leehey K, Shisslak CM. Running: an analogue of anorexia? N Engl J Med 1983; 308 (5): 251-5
36. Pope H, Gruber A, Choi P, et al. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 1997; 38: 548-57
37. Calhoun JW, Ogilvie BC, Hendrickson TP, et al. The psychiatric consultant in professional team sports. Child Adolesc Psychiatr Clin N Am 1998; 7 (4): 791-802
38. Rosen LW, McKeag DB, Hough DO, et al. Pathogenic weight-control behavior in female athletes. Phys Sportsmed 1986; 14 (1): 79-86
39. Burckes-Miller ME, Black DR. Behaviors and attitudes associated with eating disorders: perceptions of college athletes about food and weight. Health Educ Res 1988; 3: 203-8
40. Byrne S, McLean N. Elite athletes: effects of the pressure to be thin. J Sci Med Sport 2002; 5: 80-94
41. Torstveit MK, Rosenvinge JH, Sundgot-Borgen J. Prevalence of eating disorders and the predictive power of risk models in female elite athletes: a controlled study. Scand J Med Sci Sports 2008; 18: 108-18
42. Sundgot-Borgen J, Torstveit MK. Prevalence of eating disorders in elite athletes is higher than in the general population. Clin J Sport Med 2004; 14: 25-32
43. Thiel A, Gottfried H, Hesse FW. Subclinical eating disorders in male athletes: a study of the low weight category in rowers and wrestlers. Acta Psychiat Scand 1993; 88: 259-65
44. Glazer JL. Eating disorders among male athletes. Curr Sports Med Rep 2008; 7 (6): 332-7
45. Swoop RA, Murphy SM. Eating disorders and weight management in athletes. In: Murphy SM, editor. Sport psychology interventions. Champaign (IL): Human Kinetics, 1995: 307-26
46. Johnson LD, O'Malley PM, Bachman JG, et al. Monitoring the future national survey on drug use, 1975-2003, volume II. College students and adults ages 19-25. NIH publication no. 04-5508. Bethesda (MD): National Institute on Drug Abuse, 2004
47. Green GA, Uryasz FD, Petr TA, et al. NCAA study of substance abuse habits of college student-athletes. Clin J Sport Med 2001; 11 (1): 51-6
48. O'Brien CP. Alcohol and sport: impact of social drinking on recreational and competitive sports performance. Sports Med 1993; 15: 71-7
49. Miller BE, Miller MN, Verhegge R, et al. Alcohol misuse among college athletes: self-medication for psychiatric symptoms? J Drug Education 2002; 32 (1): 41-52
50. McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med 2005; 24: 885-97
51. Su TP, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760-4
52. Moss HB, Panzak GL. Steroid use and aggression [letter]. Am J Psychiatry 1992; 149: 1616
53. Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use: a controlled study of 160 athletes. Arch Gen Psychiatry 1994; 51: 375-82
54. Kerber CS. Problem and pathological gambling among college athletes. Ann Clin Psychiatry 2005; 17 (4): 243-7
55. Lesieur HR, Rosenthal RJ. Pathological gambling: a review of the literature (prepared for the American Psychiatric Association Task Force on DSM-IV. Committee on Disorders of Impulse Control Not Elsewhere Classified). J Gambling Stud 1991; 7: 5-39
56. Miller TW, Adams JM, Kraus RF, et al. Gambling as an addictive disorder among athletes: clinical issues in sports medicine. Sports Med 2001; 31 (3): 145-52
57. Cantu RC. Prevention of athletic injuries: the role of the sports medicine team. In: Mueller FO, Ryan AJ, editors. Head and neck injuries. Philadelphia (PA): FA Davis, 1991: 201-13
58. Broshek DK, Barth JT. Neuropsychological assessment of the amateur athletes. In: Bailes J, Day A, editors. Neurological sports medicine: a guide for physicians and athletic trainers. Rolling Meadows (IL): The American Association of Neurological Surgeons, 2001: 155-68
59. Freeman JR, Barth JT, Broshek DK. Sports injuries. In: Silver JM, McAllister TW, Yudofsky SC, editors. Textbook of traumatic brain injury. Washington, DC: American Psychiatric Publishing, 2001: 453-76
60. Broshek DK, Kaushik T, Freeman JR. Gender differences in outcome from sports-related concussion. J Neurosurg 2005; 102: 856-63
61. World Anti-Doping Agency [online]. Available from URL: http://www.wada-ama.org/en/ [Accessed 2009 Aug 13]
62. Blomstrand E, Celsing F, Newsholme E. Changes in plasma levels of aromatic and branched chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol Scand 1988; 133: 115-21
63. Blomstrand E, Hassmen P, Ekblom B, et al. Administra-tion of branched chain amino acids during sustained exercise-effects on performance and on plasma concentration of some amino acids. Eur J Appl Physiol 1991; 63: 83-8
64. Blomstrand E, Hassmen P, Newsholme E. Effect of branched chain amino acid supplementation on mental performance. Acta Physiol Scand 1991; 143: 225-6
65. Roelands B, Hasegawa H, Watson P, et al. The effects of acute dopamine reuptake inhibition on performance. Med Sci Sports Exercise 2008; 40 (5): 879-85
66. Parise G, Bosman MJ, Boecker DR. Selective serotonin reuptake inhibitors: their effect on high-intensity exercise performance. Arch Phys Med Rehabil 2001; 82: 867-71
67. Meeusen R, Piacentini MF, van Den Eynde S, et al. Exercise performance is not influenced by a 5-HT reuptake inhibitor. Int J Sports Med 2001; 22: 329-36
68. Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 1992; 77: 921-4
69. Strachan AT, Leiper JB, Maughan RJ. Paroxetine administration fails to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment. Exp Physiol 2004; 89.6: 657-64
70. Piacentini MF, Meeusen R, Buyse L, et al. Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor. Br J Sports Med 2004; 38: 129-33
71. Watson P, Hasegawa H, Roelands B, et al. Acute dopa-mine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol 2005; 565.3: 873-83
72. Roelands B, Hasegawa H, Watson P, et al. Performance and thermoregulatory effects of chronic bupropion administration in the heat. Eur J Appl Physiol 2009; 105 (3): 493-8
73. Piacentini MF, Meeusen R, Buyse L, et al. No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exercise 2002; 34 (7): 1189-93
74. Roelands B, Goekint M, Heyman E, et al. Acute nor-adrenaline reuptake inhibition decreases performance in normal and high ambient temperature. J Appl Physiol 2008; 105 (1): 206-12
75. Fowler NO, McCall D, Chou T-C, et al. Electrocardio-graphic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 1976; 37: 223-30
76. Waslick BD, Walsh BT, Greenhill LL, et al. Cardio-vascular effects of desipramine in children and adults during exercise testing. J Am Acad Child Adolesc Psychiatry 1999; 38 (2): 179-86
77. de Zwaan M. Exercise and antidepressant serum levels. Biol Psychiatry 1992; 32: 210-11
78. Smith DF. The effect of exercise and pain-stress on the renal clearance of lithium, sodium, potassium, and crea-tinine in the rat. Int Pharmacopsychiatry 1973; 8: 217-20
79. Miller EB, Pain RW, Skripal PJ. Sweat lithium in manic-depression. Br J Psychiatry 1978; 133: 477-8
80. Jefferson JW, Greist JH, Clagnaz PJ, et al. Effect of strenuous exercise on serum lithium level in man. Am J Psychiatry 1982; 139 (12): 1593-5
81. Tilkian AG, Schroeder JS, Kao J, et al. Effect of lithium on cardiovascular performance: report on extended ambulatory monitoring and exercise testing before and during lithium therapy. Am J Cardiol 1976; 38: 701-8
82. Cowan DA. Drug abuse. In: Harries M, Williams C, Stanish WD et al., editors. Oxford textbook of sports medicine. New York (NY): Oxford University Press, 1994: 314-29
83. Wilmore JH. Exercise testing, training, and beta-adrenergic blockade. Phys Sportsmed 1988; 16: 45-50
84. Schwenk TL. Psychoactive drugs and athletic performance. Phys Sportsmed 1997; 25 (1): 33-46
85. Marvin G, Sharma A, Aston W, et al. The effects of bus-pirone on perceived exertion and time to fatigue in man. Exp Physiol 1997; 82: 1057-60
86. Kennedy M. Drugs and Athletes: an update. Adverse Drug React Bull 1994; 169: 639-42
87. Smith GM, Beecher HK. Amphetamine sulfate and athletic performance. I: objective effects. JAMA 1959; 170: 542-57
88. Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc, 1980, 12, 1, 65-9
89. Shaikin B. Baseball's 2008 drug test results released in report. Los Angeles Times, 2009 Jan 10 [online]. Available from URL: http://articles. latimes.com/2009/jan/10/sports/ sp-newswire10 [Accessed 2010 Sep 17]
90. Hickey G, Fricker P. Attention deficit hyperactivity disorder, CNS stimulants, and sport. Sports Med 1999; 27 (1): 11-21
91. Conant-Norville DO, Tofler I. Attention deficit/hyperacti-vity disorder and psychopharmacologic treatments in the athlete. Clin Sports Med 2005; 24 (4): 829-43
92. Atkinson G, Drust B, Reilly T, et al. The relevance of melatonin to sports medicine and science. Sports Med 2003; 33 (11): 809-31
93. Gonzalez-Alonso J, Teller C, Andersen SL, et al. Influence of body temperature on the development of fatigue during prolonged exercise in the heat. J Appl Physiol 1999; 86: 1032-9
94. Walters TJ, Ryan KL, Tate LM, et al. Exercise in the heat is limited by a critical internal temperature. J Appl Physiol 2000; 89: 799-806
95. Reilly T, Atkinson G, Budgett R. Effect of low-dose temazepam on physiological variables and performance tests following a westerly flight across five time zones. Int J Sports Med 2001; 22: 166-74
96. Ito SU, Kanbayashi T, Takemura T, et al. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. Neurosci Res 2007; 59: 309-13
97. Holmberg G. The effects of anxiolytics on CFF. Pharma-copsychiatry 1982; 15 Suppl.: 49-53
98. Maddock RJ, Casson EJ, Lott LA, et al. Benzodiazepine effects on flicker sensitivity: role of stimulus frequency and size. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17: 955-70
99. Mougin F, Bourdin H, Simon-Rigaud ML, et al. Hormo-nal responses to exercise after partial sleep deprivation and after a hypnotic drug-induced sleep. J Sports Sci 2001; 19: 89-97
100. Tafti M, Besset A, Billiard M. Effects of zopiclone on sub-jective evaluation of sleep and daytime alertness and on psychomotor and physical performance tests in athletes. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 55-63
101. Grobler LA, Schwellnus MP, Trichard C, et al. Compara-tive effects of zopiclone and loprazolam on psychomotor and physical performance in active individuals. Clin J Sport Med 2000; 10 (2): 123-8
102. Paul MA, Gray G, Kenny G, et al. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003; 74 (12): 1263-70
103. Charles RB, Kirkham AJT, Guyatt AR, et al. Psychomotor, pulmonary and exercise responses to sleep medication. Br J Clin Pharmac 1987; 24: 191-7